Related Experiment Video
Updated: Jun 3, 2026

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
Acute bronchodilator effect of quercetin in experimental allergic asthma
M Joskova1, S Franova, V Sadlonova
1Department of Pharmacology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia. joskova@jfmed.uniba.sk
Objectives:
The aim of our study was to investigate the acute effect of quercetin on experimental allergic asthma after single-dose oral administration.
Background:
Airway hyperresponsiveness is one of the main features of allergic asthma. None of quercetin experimental studies analysed the acute effect of this flavonol on the reactivity of airways both, in vivo and in vitro conditions.
Methods:
Our experiment was realized 21 days after the sensitization of guinea pigs with ovalbumin suspension. Changes in the reactivity of airways were studied using the whole body plethysmography in order to compare changes of the specific airway conductance between groups with and without quercetin treatment. Also changes in the reactivity of the tracheal smooth muscle dipped into the organ bath with Krebs-Henseleit solution were measured as the reaction on cumulative doses of the bronchoconstrictor mediators histamine and acetylcholine. Quercetin was added into the solution 30 minutes before the chemical mediators. The amplitude of tracheal smooth muscle precontracted with histamine or acetylcholine was used as a tracheal smooth muscle reactivity parameter in vitro.
Results:
Our results showed that quercetin (20 mg/kg) caused significant bronchodilation, both in vivo and in vitro.
Conclusion:
Quercetin proved in laboratory conditions its ability to reduce hyperreactivity of airways as one of the main attribute of allergic asthma (Fig. 2, Ref. 23).
More Related Videos
Related Concept Videos
Asthma I: Introduction
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
